JO
STTK icon

John Overdeck’s Shattuck Labs STTK Stock Holding History

John Overdeck’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
185,947
-130,065
-41% -$811K ﹤0.01% 3408
2026
Q1 		$2.03M Sell
316,012
-121,717
-28% -$577K ﹤0.01% 2746
2025
Q4 		$1.6M Buy
437,729
+29,131
+7% +$69.5K ﹤0.01% 2605
2025
Q3 		$977K Buy
408,598
+331,664
+431% +$406K ﹤0.01% 2585
2025
Q2 		$60.9K Sell
76,934
-8,304
-10% -$8.05K ﹤0.01% 3052
2025
Q1 		$81K Sell
85,238
-45,441
-35% -$56K ﹤0.01% 2988
2024
Q4 		$158K Sell
130,679
-59,670
-31% -$73.9K ﹤0.01% 2908
2024
Q3 		$664K Sell
190,349
-38,899
-17% -$145K ﹤0.01% 2335
2024
Q2 		$885K Buy
229,248
+105,069
+85% +$854K ﹤0.01% 2057
2024
Q1 		$1.11M Buy
+124,179
New +$1.14M ﹤0.01% 1893
2022
Q4 		– Sell
-31,103
Closed -$84K – 3073
2022
Q3 		$84K Sell
31,103
-17,055
-35% -$64K ﹤0.01% 2252
2022
Q2 		$196K Sell
48,158
-123,951
-72% -$449K ﹤0.01% 2168
2022
Q1 		$733K Buy
172,109
+28,564
+20% +$162K ﹤0.01% 1837
2021
Q4 		$1.22M Buy
+143,545
New +$1.98M ﹤0.01% 2372

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

John Overdeck's STTK Position: Q2 2026 in Review

John Overdeck reduced its Shattuck Labs (STTK) stake by 41% in Q2 2026, selling an estimated $811K and leaving 185,947 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

John Overdeck first reported a position in STTK in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.03M in Q1 2026. 99 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • John Overdeck held 185,947 shares of Shattuck Labs worth $1.29M as of Q2 2026.
  • John Overdeck sold 130,065 Shattuck Labs shares in Q2 2026, an estimated $811K.
  • Shattuck Labs made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3408 holding.
  • John Overdeck first reported a position in Shattuck Labs in Q4 2021 and has held it in 14 quarters since.
  • John Overdeck's Shattuck Labs position peaked at $2.03M in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.